Angiogenesis modulation in cancer research: Novel clinical approaches

Massimo Cristofanilli*, Chusilp Charnsangavej, Gabriel N. Hortobagyi

*Corresponding author for this work

Research output: Contribution to journalReview articlepeer-review

184 Scopus citations


Angiogenesis - the formation of new blood vessels - is essential for tumour progression and metastasis. Consequently, the modulation of tumour angiogenesis using novel agents has become a highly active area of investigation in cancer research, from the bench to the clinic. However, the great therapeutic potential of these agents has yet to be realized, which could, in part, be because the traditional strategies that are used in clinical trials for anticancer therapies are not appropriate for assessing the efficacy of agents that modulate angiogenesis. Here, we discuss methods for monitoring the biological activity of angiogenic modulators, and innovative approaches to trial design that might facilitate the integration of these agents into anticancer therapy.

Original languageEnglish (US)
Pages (from-to)415-426
Number of pages12
JournalNature Reviews Drug Discovery
Issue number6
StatePublished - Jun 2002

ASJC Scopus subject areas

  • Pharmacology
  • Drug Discovery


Dive into the research topics of 'Angiogenesis modulation in cancer research: Novel clinical approaches'. Together they form a unique fingerprint.

Cite this